Our journey began in the early 1980s with a small sewing workshop focused on single-use surgical textiles.
Our vision for the future soon fueled expansion beyond textiles, venturing into drains, dressings, more complex areas like interventional medicine and today, the neurovascular field.
IHT Medical today operates in more than 70 countries and hires over 180 employees.
Drenofast®, a redon drainage system launched in the 1980s, marked the beginning of our journey into industrial manufacturing. It remains a proud part of our legacy and continues to be manufactured at our plant today.
Patients living with long-term vascular access often face challenges due to inadequate protection, leading to discomfort and risk. Together with nurses, we developed Oper Cat®, a first-of-its-kind protective pouch dressing, now helping healthcare professionals worldwide improve patient care and safety.
When it comes to a heart attack, time is critical. ST-Elevation Myocardial Infarction requires immediate action to minimize heart damage. Launched in 2010, Amicath ® II is the only catheter of its kind. Designed to efficiently manage AMI patients, allowing precise lesion visualization and targeted drug delivery, impeding no-reflow and improving intervention outcomes.
Early detection of infections at the insertion site is crucial for effective treatment. Our dressing Oper Film® CHG features a completely colorless chlorhexidine hydrogel, patented with our ClearTech® technology, offering full visibility while delivering powerful antimicrobial protection.
Stents with large and/or rectangular strut can affect blood flow, increasing the risk of cardiovascular complications. The ihtDEStiny® Stent, featuring Endoboost Technology, has an ultra-thin, oval strut design that ensures smooth, laminar blood flow. This technology further minimizes the risk of cardiovascular events.
Current liquid embolic agents face several limitations: imaging artifacts, poor diffusion, and compromised visibility, which limit staged session strategy and affect curative embolization rates. Obtura® overcomes these challenges. This isn’t just an improvement—it’s a breakthrough in embolic technology: Artifacts free, superior diffusion and enhanced procedure visibility.
We began our journey by expanding into drainage systems and wound care dressings, laying the foundation for our commitment to patient care. This initial expansion set the stage for continuous growth in the years that followed.
We entered the high-precision field of interventional cardiology. In just four years, we developed a complete portfolio of devices, becoming one of the pioneering European companies in this specialty. During this period, we also expanded our capabilities with the addition of a new 6,000 m² facility.
We launched our first range of drug-active dressings, driven by investment in proprietary biomaterials. This led to the development of Oper Film® CHG, the innovative dressing designed to reduce the risk of central venous catheter-related bloodstream infections (CRBSI).
We stand at a pivotal moment in our history, introducing a best-in-class breakthrough in neurointerventional solutions, reinforcing our commitment to clinical impact and continuous innovation.
Explore our three therapeutic areas to discover how our solutions enhance procedural control, ensure treatment safety, and improve long-term patient outcomes. Our approach is built on a deep understanding of complex clinical needs and a commitment to practical, effective solutions.
By providing advanced securement and protection solutions, this unit is dedicated to maintaining the integrity of the vascular access system and ensuring patient safety throughout the duration of treatment. Our medical products minimize risk and improve clinician confidence.
Our cardiology portfolio is engineered to optimize procedural outcomes in high-complexity coronary interventions. We provide specialists with the tools needed to navigate the most challenging clinical scenarios.
We focus on the high-stakes environment of the interventional neuroradiology field offering total procedural control and visual clarity during the endovascular treatment of complex vascular pathologies. Our specialized medical devices ensure that critical medical care is delivered with absolute precision.
Have questions about our innovative healthcare solutions? Get in touch today with us.